Pick a time period -
No more available filters You need to apply a filter before selecting newsroom

Use our filters to get your customized news. Save and subscribe to as many filters as you want, get the news that YOU are interested in right in your mailbox, RSS feed or in your personalized dashboard. Share your stories, news, multimedia and pressreleases and get a wider audience with news.cision.com.

New CEO in 24SevenOffice Group AB

Eirik Stranden will take over as the CEO of 24SevenOffice Group AB from Staale Risa with immediate effect. Eirik has been responsible for the business development division of 24SevenOffice for the last 6 months and is a former management consultant from Boston Consulting Group and EY. Staale Risa will continue in the Board of directors and be available to support Eirik in a transition period.  Staale Risa is suggested to be new deputy chairman of the board in the Company following his own ambitions to focus more on long-term strategies and development of new business areas rather than

Vår Energi sets new, ambitious climate goals – aims to be climate neutral by 2030

“The clock is ticking, and action is needed. Sustainability and environment now runs as a green thread through all activities in Vår Energi. We have established a roadmap for how we will achieve the main goal of close to zero greenhouse gas emissions in 2050. Becoming climate neutral by 2030 is an important step on the road to zero", says Vår Energi CEO, Torger Rød. The aim is to be climate neutral in Scope 1 and 2 activities by 2030 - which means net zero greenhouse gas emissions from all the 35 producing oil and gas fields where Vår Energi is operator or partner. In addition, emissions

Odfjell SE: Potential buyback of own bonds and tap issue

Odfjell SE (the "Company") has mandated Nordea and Swedbank to explore the possibility of a conditional buyback of the outstanding bonds maturing in June 2022 ISIN NO0010796238 (ODF09) and a potential tap issue of the outstanding bond maturing in September 2023 ISIN NO 0010832181, subject to market conditions. The purpose of the contemplated transactions is to part refinance ODF09 in accordance with the Company’s finance strategy. For questions, please contact: Terje Iversen, CFO:Tel: +47 932 40 359E-mail: terje.iversen@odfjell.com  Gustav Sannem, VP Finance: Tel: +47 452

Interim report July – September 2021

Third quarter in brief · Net sales amounted to 13.6 million SEK (10.5), which means a sales growth of 29 percent. · Operating profit amounted to 2.2 million SEK (-0.06). · Net profit for the period amounted to 2.3 million SEK (-0.15). · Earnings per share amounted to 0.06 SEK (-0.01). First nine months in brief · Net sales for the first nine months amounted to 40.1 million SEK (32.9), which means a sales growth of 22 percent. ·Operating profit amounted to 4.8 million SEK (-2.2). ·Profit for the period amounted to 4.8 million SEK (-2.3). ·

Flexens and Elomatic Join Forces to Develop Hydrogen Economy in Southwestern Finland

Elomatic’s subsidiary Green NortH2 Energy Oy welcomes Flexens Oy Ab as a shareholder. The joint Power-to-X expertise of Elomatic and Flexens strengthens their position in advancing hydrogen economy in Southwestern Finland, especially in the marine sector.Chairman of the board of Green NortH2 Energy Oy and CEO of Elomatic, Patrik Rautaheimo, welcomes the collaboration with Flexens. As the demand for green electricity rapidly increases for Green NortH2 Energy’s hydrogen production project in Naantali, Rautaheimo sees a special strength in Flexens’ local knowledge and contacts in energy

STABLE RESULT – HESITANT MARKET

July – September 2021 · Sales volume declined by 15% to 4,862 tonnes (5,697). · Net sales increased by 7% to SEK 222.0 (207.3) million. The organic increase was 10%. · Operating profit increased by 13% to SEK 24.7 (21.8) million and adjusted operating profit by 5% to SEK 24.8 (23.6) million. · The operating margin increased to 11.1% (10.5%) and adjusted operating margin to 11.2% (11.4%).  · Profit for the period improved by 10% to SEK 19.2 (17.5) million. · Earnings per share before dilution amounted to SEK 0.96 (0.87), and after dilution, to SEK 0.91 (0.85). · Cash

Orthex Q3: Strong performance despite high raw material prices

Orthex Corporation, Stock exchange release, November 11, 2021 at 9.00 a.m. EET Orthex Q3: Strong performance despite high raw material prices This release is a summary of Orthex Corporation’s Interim report January–September 2021. The complete report is attached to this release as a pdf-file. It is also available on Orthex’s website at https://investors.orthexgroup.com/. January–September 2021 in Brief · Invoiced sales increased by 19.9% and totalled EUR 67.0 million (55.9) · Net sales increased by 20.9% to EUR 65.6 million (54.3) · Adjusted EBITDA was EUR 12.1 million (

Humana reports third quarter and nine-month 2021 results

The good development continued in the third quarterThird quarter, July–September 2021 · Operating revenue was SEK 2,034 million (1,931), an increase of 5.3 percent. Organic growth was 3.0 percent. · Operating profit amounted to SEK 192m (172), an increase of 11.5 percent. · Net profit after tax for the period amounted to SEK 123m (109). · Basic and diluted earnings per share for the period amounted to SEK 2.55 (2.05). · Operating cash flow amounted to SEK 180m (146). Nine-month period, January–September 2021 · Operating revenue was SEK 6,078m (5,849), an increase of

Interim report January-September 2021

· Profit from property management attributable to parent company shareholders amounted to SEK 3,924m (3,146), corresponding to an increase per share by 20 % to SEK 21.04 (17.48) · Long term net asset value amounted to SEK 454.43 per share (362.77) · Rental income amounted to SEK 6,535m (6,079) · Profit after tax attributable to parent company shareholders amounted to SEK 11,120m (3,063) corresponding to SEK 59.62 per share (17.02)  Profit from property management for the period amounted to SEK 4,376m (3,682). Profit from property management attributable to parent company

Interim report

January 1 – September 30, 2021The third quarter in figures · Net sales amounted to TSEK 2,982 (2,287). · The loss after tax amounted to TSEK 8,622 (7,350). · The loss per share amounted to SEK 0.13 (0.20). · The cash flow from current operations was negative in the amount of TSEK 9,156 (6,974). · The gross margin reached 63.3% (52.7%). · Electrode sales volume increased by 20% and reached 8,304 (6,924) units. Repeat sales of electrodes to existing customers increased by 4%. January - September in figures · Net sales amounted to TSEK 7,802 (6,466). · The loss

Interim Report January - September 2021

Rise in property value and income from property managementJohn Mattson acquired and took possession of shares in the property companies HEFAB Fastighets AB (Hefab) and EFIB Aktiebolag (Efib) in the third quarter. As a result, John Mattson now has shareholdings of slightly more than 97% in Hefab and almost 100% in Efib. Property value increased SEK 5.6 billion in the quarter and amounted to SEK 14.2 billion at the end of September. The increase was largely attributable to the acquisitions of Hefab and Efib. One of our long-term goals, namely for the Group’s property value to amount to at

ENDOMINES AB Q3 2021 Business Review

ENDOMINES AB Q3 2021 Business Review   Friday Mine and Mill started initial production in Idaho, USA Pampalo Mine decline reached target depth in Ilomantsi, Finland   Endomines AB, Stock Exchange Release 11 November 2021 at 08:00 CET   Jan-Sep 2021 (Jan-Sep 2020) Operational highlights · The Friday mine commenced stoping and secondary haulage to feed and stockpile ore for the restart of the Orogrande processing facility. · The Orogrande processing facility completed commissioning at the end of Q3 2021 and is now gradually ramping up production and forecasted

Isofol Medical AB (publ) publishes interim report for January – September 2021

GOTHENBURG, Sweden, November 11, 2021 - Isofol Medical AB (publ), (Nasdaq Stockholm: ISOFOL), announced today that the company's interim report for January – September 2021 is now available on the company's website, www.isofolmedical.com.Third quarter, July –September 2021 · Net revenue amounted to TSEK 5,154 (18,439) and other revenue to TSEK 0 (0) · The result for the period amounted to TSEK -51,026 (-30,100) · Earnings per share amounted to SEK -0.32 (-0.36) · Cash and cash equivalents at September 30 amounted to TSEK 420,861 (153,612) January – September 2021 · Net

Solid Försäkring has announced the intention to list its shares on Nasdaq Stockholm

Resurs Holding AB's ("Resurs") subsidiary Solid Försäkringsaktiebolag ("Solid Försäkring"), one of the leading niche insurance companies in the Nordics within non-life insurance, has today announced its intention to list its shares on Nasdaq Stockholm (the “Listing"). The Listing is intended to be carried out after Resurs has completed the distribution of all shares in Solid Försäkring to Resurs' shareholders in accordance with the so-called Lex Asea rules. Nasdaq Stockholm AB has made the assessment that Solid Försäkring fulfils the applicable listing requirements, provided that certain

Acroud publishes interim report Jul-Sep 2021: CONTINUED STRONG NDC GROWTH AND AN OUTLOOK ON THE DUTCH MARKET

Third Quarter 2021 · Revenue amounted to EUR 6 448 (2 376) thousand, corresponding to a growth of 172% (-32%) and an organic growth of +0.3% (-30.2%). · EBITDA amounted to EUR 1 258 (961) thousand. · Profit after tax was EUR 593 (327) thousand. Adjusted profit after tax (before currency effects) was EUR 482 (162) thousand. · Earnings per share after dilution amounted to EUR 0.005 (0.004). Adjusted earnings per share (before currency effects) was EUR 0.004 (0.002). · New Depositing Customers (NDC) amounted to 39 632 (5 312) increasing by 646% (-57%). · Cash flow from

Navamedic ASA has entered into a market making agreement with Norne Securities AS

Oslo, 11. November 2021 – Navamedic ASA (OSE: NAVA) today announces it has entered into a market making agreement with Norne Securities AS. The purpose of the agreement is to enhance liquidity in the trading of the company’s shares, which are listed on Oslo Stock Exchange. The agreement is in accordance with the standard requirements of Oslo Stock Exchange. First day of market making will be Friday, 12. November 2021. For further information, please contact: Lars Hjarrand, CFO, Navamedic Mobile: +47 917 62 842 E-mail: lars.hjarrand@navamedic.com Navamedic ASA is a Nordic

AFRY X becomes a new Division and Per Kristian Egseth is appointed member of the Group Executive Management

Effective 1 January 2022, AFRY X becomes a new division with approximately 1 BSEK in revenue and around 800 digital experts. With this change AFRY brings together leading digital expertise and technologies in the AFRY X Division to create a significant digital player in its core markets. Per Kristian Egseth will lead the new Division and become part of the Group Executive Management.With a total of 2000 digital experts across all divisions, AFRY has during the past years strengthened its position in digitalisation both through organic growth and selective acquisitions. As a next step, AFRY’

Stora Enso appoints René Hansen as EVP, Head of Brand and Communications

STORA ENSO OYJ STOCK EXCHANGE RELEASE 11 November 2021 at 9.00 EETStora Enso has appointed René Hansen as EVP, Head of Brand and Communications and a member of the Group Leadership Team. He will start in February 2022 and be based in Stockholm.René Hansen is a Norwegian citizen and he joins Stora Enso from a position as Vice President, Head of Brand Management at Yara International, the world’s leading fertilizer company. Prior to this, he held several global marketing and brand executive roles at companies such as TOMRA Systems, Zound Industries and Burton Snowboards. René has spent over

Clavister Q3 2021: Recurring revenues up 24%, positive EBITDA

November 11, 2021, Örnsköldsvik, Sweden. Clavister, a leader in high-performance cybersecurity solutions, released its latest quarterly report for 2021.“We continue to grow our recurring revenues, up by 24% year-on-year in the third quarter. This is in line with our strategic direction of shifting to a pre-dominantly recurring revenue business model. Strong gross margin of 87% combined with controlled OPEX provided for positive EBITDA in the quarter.” John Vestberg, President and CEO The Third Quarter · Order Intake amounted to 26.5 (35.1) MSEK. · Net Sales amounted to 33.1 (

Double win for Sweco when the Stockholm and Uppsala regions’ electricity grids is future-proofed

Comprehensive work to upgrade and future-proof the electricity grids in the Stockholm and Uppsala regions has been commenced by Svenska kraftnät. In a short period of time, Sweco has won two new assignments.Svenska kraftnät will strengthen the Stockholm and Uppsala regions’ electricity grids to meet future needs of secure electricity supply. Under an assignment from the Swedish Energy Agency, Sweco has previously estimated that Sweden’s electricity consumption could increase by over 20 TWh by 2030. Sweco has now been tasked with the project planning of a new 26 km overhead transmission

Read original

Interim report for the period January 1 - September 30, 2021

THE EFFICIENCY PROGRAM HAS BEEN IMPLEMENTED INCREASED FOCUS ON PROFITABILITY AND PRODUCT DEVELOPMENT During the quarter, Climeon has, implemented the cost efficiency program presented in July, with the target of creating stronger profitability and a more focused organization. In parallel, the company has continued the development of a new generation of Heat Power technology, with increased profitability as its main goal. Climeon will initially focus on optimizing the product for marine use, and then cost-effectively adapting it to existing and new markets. The collaboration with

Orthex Corporation's financial information and AGM in 2022

Orthex Corporation, Stock Exchange Release, 11 November 2021 at 8:30 a.m. EET Orthex CORPORATION’S FINANCIAL INFORMATION and AGM IN 2022 Orthex Corporation will publish its financial reports in 2022 as follows: · 9 March 2022, Financial Statements release for 2021 · 11 May 2022, Interim report January–March 2022 · 25 August 2022, Half-year financial report January–June 2022 · 11 November 2022, Interim report January–September 2022 Orthex's Annual Report 2021 including the Report of the Board of Directors and the Financial Statements for the period 1 January–31

SynAct Pharma takes advantage of new toxicology results and new tablet formulation to re-design and optimize the study programme with AP1189 in Nephrotic Syndrome

SynAct Pharma today announces that the company intends to redesign the phase 2 development program with the lead asset AP1189 in Nephrotic Syndrome (NS). The aim of this is to take advantage of longer treatment periods now possible following new preclinical documentation published on November 5th this year. In addition, the redesigned study will take advantage of the company´s newly developed tablet, published on October 15 this year.The major aim of the redesign will be to increase dosing from four weeks to three months and change from dosing with the AP1189 suspension and instead dose

RugVista Group AB (publ) interim report January – September 2021

Strong growth and solid profitability Third quarter 2021 highlights · Net revenue was SEK 141.0 (116.4) million representing a growth of 21.1% (20.7%). · Organic net revenue growth was 29.6%. · Gross margin increased to 64.4% (63.2%). · EBIT was SEK 22.9 (24.4) million and EBIT margin was 16.2% (21.0%). · Profit for the period was SEK 17.9 (18.8) million. · Earnings per share was SEK 0.86 (0.93). · The average NPS (Net Promotor Score) value was 66 (67). January – September 2021 highlights · Net revenue was SEK 486.2 (351.4) million representing a growth of

There are no items matching the current filter
There are no more items matching the current filter
Back to top